New JAK1 Agent Beats Humira in Rheumatoid Arthritis

(MedPage Today) -- Thrombotic events balanced between upadacitinib, adalimumab, and placebo
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news